To Brand Is Human is a message strategy consultancy that helps sustainability- and science-led enterprises win over their audience with compelling brand stories that translate what they do into why it matters.I helped clients with:Brand Message strategy:-Target audience profiling, segmentation, customer journeys-Competitive brands' analysis-Mission, Vision, Purpose, Values statements-Brand positioning, value proposition and story-Brand personality and tone of voice-Brand message hierarchy and proof pointsContent strategy and execution: -Content pillars and storytelling development-Editorial calendar and channel development-Social media campaigns: copywriting, distribution, KPIs and reporting-Social media style guides-Staff training-Other: newsletters, web design and copywriting, journalist pitches and print materials

Designed and taught the Digital and Mobile Marketing course for the International Global Communications degree at the Institut Supérieur de Communication et Publicité

• Led a strategic marketing team to generate the brand strategy of 10 Neurology pipeline products. Worked closely with R&D to gain alignment and oversee the implementation of the strategies in the clinical development plans.• Created and implemented best practice guidelines for brand strategy development up to proof-of-concept stage, across therapeutic areas in the Emerging Brands Marketing department at HQ.• Developed and rolled out a process for the fast and streamlined commercial evaluation of licensing opportunities across the Marketing department at HQ.• Evaluated the commercial potential of more than 60 global licensing opportunities in the Neurology space

• Identified, managed and co-led negotiation of a $146M licensing agreement for a chronic pain product, for which I received the Astellas President‘s Award. The deal was nominated for Scrip award in 2010.• Established the commercial strategy of the Astellas Pain franchise in collaboration with the heads of Research and Development. Put brand strategy plans in place for 7 pipeline compounds.• Responsible for business development in Europe in Neurology. Evaluated the commercial potential of over 80 opportunities.

• Responsible for business development in Europe in Neurology, GI and Oncology. Evaluated over 50 opportunities.• Managed and co-led negotiations for a $56M licensing agreement for the European rights of a Neurology product.

LTN was a JV between the London Business School and the academic hub in the S.E. of U.K. with the mission to match industry needs with technologies and expertise found in academia. I offered services to the pharma industry leveraging Key Opinion Leaders’ expertise e.g. running advisory boards, conducting market research, carrying out technology assessments, placing consultancy projects etc. I managed a network of over 150 KOLs and a CRM system of over 70 projects.

Carried out research in brain development, combining molecular and cell biology. Managed Ph.D. and M.Sc. students, applied for and won research grants and managed their budget.